E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 2.4 EUR -22.88%
Market Cap: 229.4m EUR

EV/EBIT
Enterprise Value to EBIT

-13.4
Current
40.1
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-13.4
=
Enterprise Value
241.5m EUR
/
EBIT
-18m EUR
All Countries
Close
Market Cap EV/EBIT
FR
Euroapi SAS
PAR:EAPI
228m EUR -13.4
US
Eli Lilly and Co
NYSE:LLY
985.4B USD 38.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
506.1B USD 21.4
CH
Roche Holding AG
SIX:ROG
251.4B CHF 13.3
UK
AstraZeneca PLC
LSE:AZN
209.2B GBP 157.9
CH
Novartis AG
SIX:NOVN
206.7B CHF 14.8
US
Merck & Co Inc
NYSE:MRK
246.7B USD 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 10.7
IE
Endo International PLC
LSE:0Y5F
209B USD 830.4
US
Pfizer Inc
NYSE:PFE
142.4B USD 10.1
EBIT Growth EV/EBIT to Growth
FR
E
Euroapi SAS
PAR:EAPI
Average EV/EBIT: 1 881
Negative Multiple: -13.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.5
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.4
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
157.9
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
1%
10.7
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-4.7
2-Years Forward
EV/EBIT
-9.5
3-Years Forward
EV/EBIT
13.3